Triple

T19157519
Position Surface form Disambiguated ID Type / Status
Subject Organon & Co. (historical, later spun off) E468962 entity
Predicate parentCompanyAlsoKnownAs P5441 FINISHED
Object Merck Sharp & Dohme (MSD) outside the United States and Canada NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Merck Sharp & Dohme (MSD) outside the United States and Canada | Statement: [Organon & Co. (historical, later spun off), parentCompanyAlsoKnownAs, Merck Sharp & Dohme (MSD) outside the United States and Canada]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Merck Sharp & Dohme (MSD) outside the United States and Canada
Context triple: [Organon & Co. (historical, later spun off), parentCompanyAlsoKnownAs, Merck Sharp & Dohme (MSD) outside the United States and Canada]
  • A. Merck & Co. chosen
    Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
  • B. Merck Life Science
    Merck Life Science is the life science business of Merck KGaA, providing products and technologies for research, biotechnology, and pharmaceutical development worldwide.
  • C. Merck KGaA
    Merck KGaA is a German multinational science and technology company specializing in healthcare, life science, and electronics.
  • D. Pharmaceutical Research and Manufacturers of America
    Pharmaceutical Research and Manufacturers of America is a major U.S. trade association representing leading biopharmaceutical and drug research companies.
  • E. Bristol Myers Squibb
    Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: parentCompanyAlsoKnownAs
Context triple: [Organon & Co. (historical, later spun off), parentCompanyAlsoKnownAs, Merck Sharp & Dohme (MSD) outside the United States and Canada]
  • A. formerParentCompany
    Indicates that one entity previously served as the parent company of another but no longer holds that status.
  • B. ultimateParentCompany
    Indicates that one company is the highest-level controlling entity in a corporate ownership structure, with no parent company above it.
  • C. laterParentCompany chosen
    Indicates that one entity became the parent company of another entity at a later point in time, after some prior state or relationship.
  • D. parentCompanyOfProducer
    Indicates that one company is the parent company that owns or controls a producer entity.
  • E. associatedCompanyFoundedAs
    Indicates that one company was originally established or created under a former name or organizational form that is now associated with the current company.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8dd084ff48190ac0f8c46ee722629 completed April 10, 2026, 11:20 a.m.
NER Named-entity recognition batch_69e5eeba91a081909c04d61d6117da06 completed April 20, 2026, 9:15 a.m.
PD Predicate disambiguation batch_69e4b9b83d6881908e6271c620f74100 completed April 19, 2026, 11:17 a.m.
Created at: April 10, 2026, 12:06 p.m.